CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 764 enrolled
Drug / intervention
MyPEEPS Mobilebehavioral
Likely dose
MyPEEPS Mobile app (frequency and duration not specified)AI-extracted
Key inclusion· 7
  • Self-identify as male, nonbinary, or genderqueer
  • Male sex assigned at birth
  • Live in the United States or its territories
  • Own or have access to a mobile device (smartphone or tablet)
Key exclusion· 1
  • HIV-positive status

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03167606
NCT03167606N/ACompleted

A Pragmatic Clinical Trial of MyPEEPS Mobile to Improve HIV Prevention Behaviors in Diverse Adolescent MSM

Columbia University·interventional·Posted May 30, 2017·Updated Feb 23, 2023

In Brief

A clinical study evaluating MyPEEPS Mobile for HIV Infections. Completed, enrolled 764 participants across 4 sites.

Detailed Summary

The proposed MyPEEPS Mobile intervention is a novel and evidence-driven intervention using mobile technology to deliver HIV prevention information specifically developed for at-risk young men who have sex with men (YMSM). This will be the one of the first studies to test the efficacy of a scaled-up, mobile version of an existing human immunodeficiency virus (HIV) prevention intervention originally developed for, designed by, and piloted for, a diverse group of YMSM. MyPEEPS Mobile will be tested in an randomized controlled trial with racially and ethnically diverse HIV-negative or unknown status YMSM aged 13-18 at four geographically diverse sites: Birmingham, Chicago, New York City, and Seattle, allowing for increased generalizability of findings.

Study Details

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedMay 30, 2017
Enrollment StartJun 1, 2018
Primary CompletionMay 13, 2021
TodayJul 2, 2026
Enrollment to primary: 2.9 yearsPosted 9.1 years ago

Interventions

MyPEEPS Mobilebehavioral

Mobile technology to deliver HIV prevention information specifically developed for at-risk YMSM.